Previous reports have showed an enhanced IL-17A expression regardless of eosinophilic or noneosinophilic inflammation of CRSwNP [11], despite different results about the role of IL-17A in the severity and development of NPs in the different regions [12, 13]. The gene discussed is IL17A; the disease is nail-patella syndrome.